NYSE:DGXHealthcare
Is Quest Diagnostics (DGX) Stock Still Worth More Than Its Price?
Quest Diagnostics stock has delivered a 79.9% return over the past three years, and the key question now is whether that strong run is still supported by the current valuation. The Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable gap to the share price, while the broader market multiples suggest the stock is closer to fairly priced.
Over the past three years Quest Diagnostics has returned 79.9%, which puts the recent share price firmly in focus for anyone reassessing...